BAA-009
BAA-009 is a selective and orally active PKMYT1 inhibitor with an IC50 of <50 nM. BAA-009 inhibits cancer cells proliferation and inhibits tumor growth in OVCAR3 xenograft mice. BAA-009 can be used for the research of cancer, such as ovarian cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C28H35N5O4S
- Masse moléculaire:537.67
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
PKMYT1 <50 nM (IC50) |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:human ovarian cancer OVCAR3 xenograft mice models[1]
-
Dosage:40, 120 mg/kg
-
Administration:p.o.; qd for 17 days
-
Result:Inhibited tumor growth.
Showed stronger antitumor activity combined with Irinotecan (HY-16562) and ADC Mirvetuximab exatecan.
Chemical Information
-
Masse moléculaire 537.67
-
Formule C28H35N5O4S
-
SMILES
CC(C)(C)C(OC1=CC=C(C)C(NC(C2=CN=C(NC3=NC(NC(C(C)(C)C)=O)=CC=C3C)S2)=O)=C1C)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BAA-009 Related Classifications
HY-182791 Related Classifications
Powered by Bioz